| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $1.3M | +15.0% | +0.3% |
| SG&A Expense | $744K | -33.2% | -23.0% |
| Operating Income | -$2.0M | +9.1% | +9.7% |
| Net Income | -$2.0M | +10.4% | +10.3% |
| EPS (Basic) | -$0.09 | +18.2% | +35.7% |
| EPS (Diluted) | -$0.09 | +18.2% | +35.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.2M | -37.6% | +26.4% |
| Current Assets | $3.4M | -36.2% | +23.9% |
| Total Assets | $10.2M | -16.7% | +1.9% |
| Current Liabilities | $1.1M | -10.9% | -11.1% |
| Total Liabilities | $1.1M | -8.3% | — |
| Stockholders' Equity | $9.2M | -17.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | — |
| Capital Expenditures | $84K | — | — |
| Investing Cash Flow | -$84K | — | — |
| Financing Cash Flow | $7.3M | — | — |
| Free Cash Flow | -$5.7M | — | — |
| +3.6% |